Results 121 to 130 of about 24,961 (206)

Human T-cell lymphotropic virus type 1 (HTLV-1)-associated bronchioloalveolar disorder required differentiation from fibrotic chronic hypersensitivity pneumonitis. [PDF]

Radiol Case Rep, 2022
Chikasue T, Sumi A, Tanoue S, Abe T, Tominaga M, Fukuoka J, Fujimoto K.   +6 more
europepmc   +1 more source

Effect of Teriflunomide on Cells From Patients With Human T-cell Lymphotropic Virus Type 1-Associated Neurologic Disease. [PDF]

Neurol Neuroimmunol Neuroinflamm, 2021
Enose-Akahata Y, Ngouth N, Ohayon J, Mandel M, Chavin J, Turner TJ, Jacobson S.   +6 more
europepmc   +1 more source

Case Report: Atypical Cutaneous Presentation of Human T-cell Lymphotropic Virus Type 1-Related Adult T-cell Lymphoma. [PDF]

Am J Trop Med Hyg, 2021
Avallone G, Trunfio M, Mastorino L, Agostini A, Merli M, Rubatto M, Caracciolo D, Calcagno A, Senetta R, Fierro MT, Quaglino P, Ribero S.   +11 more
europepmc   +1 more source

Molecular and immunogenic analysis of Jembrana disease virus Tat

, 2006
Jembrana disease is an acute and severe disease of Bali cattle (Bos javanicus) endemic in Indonesia that is caused by a bovine lentivirus designated Jembrana disease virus (JDV).
Setiyaningsih, Surachmi
core   +1 more source

Seroprevalence of human T-cell lymphotropic virus type 1 infection (HTLV1) in different patients in the north of Iran

, 2013
Human T-cell lymphotropic virus type-1 (HTLV1) is a lymphotropic virus which can contribute to carcinogenesis in adult T-cell leukemia, myleopathy and other disorders. 20 million people are affected by this virus in the world.
Farid, R, Torabizadeh, J, Nazari, Z, Ghaffari, J, Naghshvar, F, Madani, F   +5 more
core   +2 more sources

Candidate Polyanionic Microbicides Inhibit Human T-Cell Lymphotropic Virus Type 1 Receptor Interactions, Cell-Free Infection, and Cell-Cell Spread

, 2009
The human T-cell lymphotropic virus type 1 (HTLV-1) is the cause of adult T-cell leukemia and inflammatory diseases including HTLV-1-associated myelopathy/tropical spastic paraparesis.
Brighty, David W., Romer, Daniela, Robson, CL, Sattentau, Quentin J., Sattentau, Quentin, Brighty, DW, Romer, D, Sattentau, QJ, Robson, Cynthia L.   +8 more
core   +1 more source

Rational design of chimeric Multiepitope Based Vaccine (MEBV) against human T-cell lymphotropic virus type 1: An integrated vaccine informatics and molecular docking based approach. [PDF]

PLoS One, 2021
Tariq MH, Bhatti R, Ali NF, Ashfaq UA, Shahid F, Almatroudi A, Khurshid M.   +6 more
europepmc   +1 more source

Neurological Manifestations of the Human T-lymphotropic Virus Type 1

, 2017
The human T cell lymphotropic virus type 1 (HTLV-1) is a retrovirus that infects about 20 million individuals worldwide. Its typical neurological presentation is of a chronic, slowly progressive myelopathy named “HTLV-1-associated myelopathy/tropical ...
Abelardo Q-C Araujo
core   +1 more source

Response to: RSBMT-2018-0270.R2 - Pain and quality of life in human T cell lymphotropic virus type 1 associated myelopathy or tropical spastic paraparesis after home-based exercise protocol: Randomized clinical trial. [PDF]

Rev Soc Bras Med Trop, 2022
Macêdo MC, Mota RS, Patrício NA, Baptista AF, Andrade Filho AS, Sá KN.   +5 more
europepmc   +1 more source

Constraints on the CD8 T cell response in chronic HBV infection [PDF]

, 2009
The inflamed liver in chronic hepatitis B virus infection (CHB) is characterised by a large influx of non-virus specific CD8 T cells, which we hypothesize could provide insights into mechanisms of failure of viral control and liver damage in this setting.
Das, A., Das, A
core